SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-062153
Filing Date
2018-10-15
Accepted
2018-10-15 17:22:35
Documents
5
Period of Report
2018-10-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-36350_28k.htm 8-K 49153
2 EX-2 a18-36350_2ex2.htm EX-2 891055
3 EX-10 a18-36350_2ex10.htm EX-10 1374780
4 EX-99 a18-36350_2ex99.htm EX-99 20971
5 GRAPHIC g363502myi001.jpg GRAPHIC 2847
  Complete submission text file 0001104659-18-062153.txt   2341390
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 181123088
SIC: 2834 Pharmaceutical Preparations